GO curators for mouse genes have assigned the following annotations to the gene product of Oprm1. (This text reflects annotations as of Wednesday, January 23, 2013.) Summary from NCBI RefSeq
This gene encodes the mu opioid receptor which is where drugs such as morphine and other opioids have pharmacological effects. Alternatively spliced transcript variants have been found for this gene, however, many of these variants may be NMD candidates. [provided by RefSeq, Jul 2008]Summary text based on GO annotations supported by experimental evidence in mouse
Researchers have inferred from direct assay, that the gene product of Oprm1
participates in the following biological processes:
Filliol D et al. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet, 25:195-200. (PubMed:10835636)
Liu XY et al. (2011) Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids. Cell, 147:447-58. (PubMed:22000021)
Narita M et al. (2003) Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci, 23:1006-12. (PubMed:12574430)
Noble F et al. (1996) Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Brain Res, 716:107-17. (PubMed:8738226)
Rios C et al. (2006) mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol, 148:387-95. (PubMed:16682964)
Sora I et al. (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A, 94:1544-9. (PubMed:9037090)